Target intelligence / Profile preview

Fluid volume (Extracellular fluid volume) (ECFV)

Target
ECFV
Molecular classification
Other
01

Overview

Fluid volume represents the total quantity of fluid within the body's physiological compartments, specifically the extracellular fluid (ECF) and intravascular plasma volume (StatPearls, 2023). It is not a single molecular target but rather a physiological state regulated by a network of receptors, transporters, and hormones, including the renin-angiotensin-aldosterone system (RAAS) and natriuretic peptides (NIH, 2022). Maintaining fluid volume is essential for hemodynamic stability, tissue perfusion, and electrolyte balance (StatPearls, 2023). In clinical practice, fluid volume is managed through pharmacological agents like diuretics, which target specific renal transporters (e.g., NKCC2, NCC) to promote water and salt excretion, or through intravenous fluids to address depletion (StatPearls, 2024). Pathological alterations in fluid volume are central to the pathophysiology of conditions such as congestive heart failure, cirrhosis, and chronic kidney disease, where volume overload occurs, as well as dehydration and shock, which involve volume depletion (NIH, 2022). Monitoring fluid status often involves clinical biomarkers such as B-type natriuretic peptide (BNP) and physical assessments like weight changes or central venous pressure (PubMed, 2021). Therapeutic strategies aim to modulate the underlying molecular mechanisms to achieve euvolemia and prevent complications like pulmonary edema or organ hypoperfusion (StatPearls, 2023).

Other names
Extracellular fluid volumeBlood volumePlasma volumeIntravascular volume
02

Mechanism of action

Drugs modulate fluid volume by inhibiting renal ion transporters, antagonizing hormonal receptors (e.g., V2, MR), or altering osmotic/oncotic pressure to regulate sodium and water homeostasis (StatPearls, 2024).

03

Biological functions

Hemodynamic stabilityOsmoregulationTissue perfusionElectrolyte balance
04

Disease associations

HypertensionHeart failureEdemaDehydrationChronic kidney diseaseShock
05

Safety considerations

Electrolyte imbalanceHypotensionAcute kidney injuryDehydration
06

Interacting drugs

Furosemide

6 more in the full profile.

07

Biomarkers

B-type natriuretic peptide (BNP)Serum sodiumHematocritCentral venous pressure (CVP)Body weight change

Beyond the preview

Go deeper on Fluid volume (Extracellular fluid volume) (ECFV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fluid volume (Extracellular fluid volume) (ECFV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call